CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
43.10
-1.40 (-3.15%)
Apr 24, 2025, 1:54 PM CST
-21.49%
Market Cap 9.32B
Revenue (ttm) 3.58M
Net Income (ttm) -212.23M
Shares Out 214.01M
EPS (ttm) -0.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 287,053
Average Volume 366,057
Open 44.05
Previous Close 44.50
Day's Range 41.95 - 44.50
52-Week Range 38.05 - 72.30
Beta -0.24
RSI 42.01
Earnings Date May 8, 2025

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.